We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Arcosa
ACA
$7.11B
| $7.1M | 0.07% |
161,095
-18,305
| -10% | -$805K |
|
277
Ionis Pharmaceuticals
IONS
$8.93B
| $7.09M | 0.07% |
149,472
-8,027
| -5% | -$446K |
|
278
Tenable Holdings
TENB
$3.47B
| $7.07M | 0.07% |
187,219
-177,531
| -49% | -$6.09M |
|
279
GE Aerospace
GE
$364B
| $7.03M | 0.07% |
226,316
+124,062
| +121% | +$4.03M |
|
280
APA Corp
APA
$13B
| $6.87M | 0.07% |
+725,324
| New | +$9.93M |
|
|
ODP
281
DELISTED
ODP
ODP
| $6.85M | 0.07% |
351,967
-112,947
| -24% | -$2.41M |
|
282
Sportsman's Warehouse
SPWH
$44.9M
| $6.79M | 0.07% |
+474,520
| New | +$7.3M |
|
|
PDM
283
Piedmont Realty Trust
PDM
$1.24B
| $6.78M | 0.07% |
499,328
-61,534
| -11% | -$953K |
|
|
GLUU
284
DELISTED
Glu Mobile Inc.
GLUU
| $6.74M | 0.07% |
877,618
-312,540
| -26% | -$2.62M |
|
285
Usana Health Sciences
USNA
$419M
| $6.71M | 0.07% |
91,076
+1,027
| +1% | +$82.4K |
|
286
Biogen
BIIB
$30.9B
| $6.45M | 0.07% |
22,737
+20,562
| +945% | +$5.74M |
|
|
AVID
287
DELISTED
Avid Technology Inc
AVID
| $6.45M | 0.07% |
752,951
+21,702
| +3% | +$174K |
|
|
ALXN
288
DELISTED
Alexion Pharmaceuticals
ALXN
| $6.43M | 0.07% |
56,192
+46,137
| +459% | +$4.98M |
|
289
MYR Group
MYRG
$5.01B
| $6.4M | 0.07% |
172,216
-8,895
| -5% | -$315K |
|
290
Advance Auto Parts
AAP
$3.53B
| $6.38M | 0.07% |
41,533
+290
| +0.7% | +$43.7K |
|
291
Nutanix
NTNX
$16.1B
| $6.37M | 0.07% |
287,235
+82,968
| +41% | +$1.9M |
|
|
NPTN
292
DELISTED
NEOPHOTONICS CORP
NPTN
| $6.36M | 0.07% |
1,043,922
+127,373
| +14% | +$972K |
|
293
A10 Networks
ATEN
$2.07B
| $6.33M | 0.07% |
993,014
+337,711
| +52% | +$2.59M |
|
294
Cullen/Frost Bankers
CFR
$10.5B
| $6.31M | 0.07% |
98,716
-29,282
| -23% | -$2.05M |
|
295
Sturm, Ruger & Co
RGR
$603M
| $6.3M | 0.07% |
103,088
-29,771
| -22% | -$2.19M |
|
|
TGI
296
DELISTED
Triumph Group
TGI
| $6.26M | 0.06% |
962,050
-49,023
| -5% | -$364K |
|
297
Sprouts Farmers Market
SFM
$7.44B
| $6.26M | 0.06% |
299,181
-96,773
| -24% | -$2.32M |
|
298
Edwards Lifesciences
EW
$49.4B
| $6.24M | 0.06% |
78,133
+52,806
| +208% | +$4.12M |
|
|
SGI
299
Somnigroup International
SGI
$14.4B
| $6.21M | 0.06% |
278,544
-36,396
| -12% | -$752K |
|
300
Amkor Technology
AMKR
$10.6B
| $6.17M | 0.06% |
551,135
+114,567
| +26% | +$1.42M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.